Mengying Yan

Dr. Mengying Yan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Membrane Science
Verified
Journal Article
Closed access
EPEmma Piacentini
Emma Piacentini
MYMengying Yan
Mengying Yan
Lidietta GiornoLidietta Giorno
Lidietta Giorno

27 May 2024 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
WYWu Yiyong
Wu Yiyong
LWLulu Wang
Lulu Wang
MYMengying Yan
Mengying Yan
XWXufang Wang
Xufang Wang
XLXin Liao
Xin Liao
YLYi Lu
Yi Lu

12 September 2025 in Science Advances
Verified
Journal Article
Open access
YLYuanzhe Li
Yuanzhe Li
MYMengying Yan
Mengying Yan
XHXie He
Xie He
CLCunman Liang
Cunman Liang
HLHeng Liu
Heng Liu
NZNi Zhao
Ni Zhao
Intelligent wearable devices with integrated sensing and drug-releasing functions are essential for delivering real-time and personalized interventions. Current approaches typically rely on interconnected modules, facing challenges such as large footprint, high energy consumption, and fabrication complexity. To address these limitations, we introduce a modified organic electrochemical transistor structure called the organic electrochemical transceiver (OECTC). The OECTC leverages the electronic wettability switch characteristic of conjugated polymers to convert sensed signals into a valve mechanism for controlling the release of chemical substances (e.g., drugs and neurotransmitters). This provides an all-in-one solution for synchronized signal recording and substance release for physiological modulation. The applications of the OECTC in intelligent wearable devices for managing type II diabetes and as a neural amplifier or inverter for neurotransmitter modulation are demonstrated.

13 March 2022 in International Journal of Electrochemical Science
Verified
Journal Article
Open access
KDKeqiang Ding
Keqiang Ding
FSFujuan Shi
Fujuan Shi
DZDongyue Zhang
Dongyue Zhang
BLBoxia Li
Boxia Li
JCJiasheng Chen
Jiasheng Chen
BWBob Wang
Bob Wang

19 October 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SBSara Baldassari
Sara Baldassari
MYMengying Yan
Mengying Yan
GAGiorgia Ailuno
Giorgia Ailuno
Guendalina ZuccariGuendalina Zuccari
Guendalina Zuccari
ABAnna Maria Bassi
Anna Maria Bassi
GCGabriele Caviglioli
Gabriele Caviglioli
Background/Objectives: Three-dimensional (3D) cell culture technologies allow us to overcome the constraints of two-dimensional methods in different fields like biochemistry and cell biology and in pharmaceutical in vitro tests. In this study, a novel 3D hydrogel sponge scaffold, composed of a crosslinked polyacrylic acid forming a porous matrix, has been developed and characterized. Methods: The scaffold was obtained via an innovative procedure involving thermal treatment followed by a salt-leaching step on a matrix-containing polymer along with a gas-forming agent. Based on experimental design for mixtures, a series of formulations were prepared to study the effect of the three components (polyacrylic acid, NaHCO3 and NaCl) on the scaffold mechanical properties, density, swelling behavior and morphological changes. Physical appearance, surface morphology, porosity, molecular diffusion, transparency, biocompatibility and cytocompatibility were also evaluated. Results: The hydrogel scaffolds obtained show high porosity and good optical transparency and mechanical resistance. The scaffolds were successfully employed to culture several cell lines for more than 20 days. Conclusions: The developed scaffolds could be an important tool, as such or with a specific coating, to obtain a more predictive cellular response to evaluate drugs in preclinical studies or for testing chemical compounds, biocides and cosmetics, thus reducing animal testing.